Hemoglobinopathy Interpretation
Use
The Hemoglobinopathy Interpretation test is useful for interpreting results in the evaluation of thalassemias and hemoglobinopathies. It is also applicable in the evaluation of microcytosis. This test provides extensive and economical diagnosis and classification of hemoglobinopathies or thalassemias, including complex disorders. It aids in the diagnosis of hereditary persistence of hemoglobin. The test covers a broad spectrum, including tests for alpha thalassemias, beta thalassemias, delta-beta thalassemia, hereditary persistence of fetal hemoglobin (HPFH), and all known hemoglobin variants.
Special Instructions
Not provided.
Limitations
The Hemoglobinopathy Interpretation may not detect all hemoglobin disorders conclusively, especially in cases of iron deficiency which can mimic thalassemias. It predominantly targets the evaluation of microcytosis but may need structural or molecular studies for definitive results. Various conditions causing diagnostic confusion, like improper specimen collection or handling, inappropriate test selection, and interfering substances, should be taken into consideration.
New York Approved
Methodology
Other
Biomarkers
LOINC Codes
- 14869-2 - Path Rev Bld -Imp
- 13514-5 - Hgb Fract Bld Elph-Imp
Result Turnaround Time
2-25 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided
Container
EDTA
Storage Instructions
Refrigerated
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 7 days |